BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death

Table 1

Characteristics of primary AML samples.

BSMS number	Sex	Age	Diagnosis	Cytogenetics	Gene Mutations
0131	F	75	AML	Normal	None detected
1007	M	58	AML	Normal	NPM1 mutated
1010	M	76	AML	Normal	None detected
1013	M	76	AML	Normal	None detected
1015	M	85	AML	Normal	None detected
1019	M	33	AML	Inv16	None detected
1022	M	76	AML	Normal	None detected
1024	M	68	AML	Normal	None detected
1026	M	75	AML	Normal	None detected
1030	M	70	AML	Normal	DNMT3A, FLT3, TET, SRSF2 mutations
1031	M	60	AML	Normal	None detected
1032	M	52	AML	Normal	None detected
1033	M	72	AML	Normal	TET2, SRSF2, ASXL1, RUNX1 mutations
1036	M	74	AML	Normal	None detected
1037	M	48	AML	Normal	NPM1, FLT3 mutated
1038	M	74	AML	Monosomy 7	None detected
1041	F	81	AML	Normal	None detected
1045	M	57	AML	Normal	FLT3 mutated